Divergene collaborates closely with CROs, CDMOs, cell and gene therapy (CGT) companies to enhance their next-generation sequencing capabilities. Our support spans from upstream vector engineering to downstream vector QC, ensuring comprehensive assistance for your gene therapy endeavors. Trust Divergene for bolstering your sequencing capabilities throughout the entire process.
Whether you are looking for AAV capsid library enrichment or interested in post-infection solutions, Divergene utilizes the latest technologies on the market, including PacBio® long-read (>10kb) and Illumina® short-read sequencing, to provide custom, in-depth solutions for complex AAV gene therapy applications.
- AAV Genome Sequencing
- Vector Discovery
- Confirm Plasmid Sequences
- Quantify AAV Expression
- Validate Packaged Material
- Capsid Engineering
- scRNA Sequencing
- Transcriptome Analysis
If any of the applications interest you, get in touch with us.
Custom NGS Analysis Pipeline Development
We’re experts on bioinformatics software; if you want something built, you probably want us. And we will deliver.
If you answered yes to one or more of these questions, get in touch with us.
Why Choose Us
Divergene utilizes Illumina and other cutting-edge sequencing platforms. For information on our NGS platforms as well as recommended configurations of your projects, please contact us.